Fear of cancer recurrence in Korean women after breast cancer treatment: A mixed methods study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Se Jin | - |
dc.contributor.author | Shin, Nah-Mee | - |
dc.date.accessioned | 2022-02-18T03:40:53Z | - |
dc.date.available | 2022-02-18T03:40:53Z | - |
dc.date.created | 2022-02-08 | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 1462-3889 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/136177 | - |
dc.description.abstract | Purpose: This study aimed to identify the fear of cancer recurrence (FCR) among Korean breast cancer survivors and further explore their experiences based on their level of FCR. Methods: A mixed-methods study was conducted with a quantitative approach (phase I) followed by a qualitative approach (phase II) between August 2019 and February 2020.70 participants who completed the FCR inventory questionnaire were categorized into either high or low groups based on their FCR level. In phase II, in-depth interviews with 14 participants from phase I were conducted to explore their specific experiences of FCR. Results: 38 participants (54.3%) experienced high levels of FCR, characterized by higher severity of FCR, more reaction to triggers, higher stress levels, more functional impairments, more insight, and frequent reassurance seeking behaviors than those with low levels of FCR. Differences in FCR levels by age were statistically significant (F = 6.83, p = .002), and participants younger than 50 years had significantly higher FCR scores than those aged 60 years and older. Of similarities and differences found between the two groups, qualitative findings showed that the experience of the high FCR group was characterized by "living with cancer but keeping a certain distance from fear of recurrence" and that of the low FCR group was characterized by "living a healing life while controlling latent fears." Conclusions: It is necessary to help those survivors who experience high FCR reduce its negative impact on their health. These findings can serve as a basis to develop a personalized approach with better understanding of the FCR among Korean women. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | SURVIVORS | - |
dc.subject | FEATURES | - |
dc.title | Fear of cancer recurrence in Korean women after breast cancer treatment: A mixed methods study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hong, Se Jin | - |
dc.contributor.affiliatedAuthor | Shin, Nah-Mee | - |
dc.identifier.doi | 10.1016/j.ejon.2021.102010 | - |
dc.identifier.scopusid | 2-s2.0-85114191482 | - |
dc.identifier.wosid | 000704347200002 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF ONCOLOGY NURSING, v.54 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF ONCOLOGY NURSING | - |
dc.citation.title | EUROPEAN JOURNAL OF ONCOLOGY NURSING | - |
dc.citation.volume | 54 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Nursing | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Nursing | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordPlus | SURVIVORS | - |
dc.subject.keywordAuthor | Breast cancer survivors | - |
dc.subject.keywordAuthor | Experience | - |
dc.subject.keywordAuthor | Fear of cancer recurrence | - |
dc.subject.keywordAuthor | Mixed-methods study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.